Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EQL Pharma AB ( (SE:EQL) ) has shared an update.
EQL Pharma AB has announced its upcoming annual general meeting, scheduled for August 21, 2025, at its premises in Lund. The agenda includes key resolutions such as the election of the Chairman, approval of financial statements, and a decision on a long-term incentive program for the CEO. The board proposes no dividends, opting to carry forward available funds, indicating a focus on reinvestment and growth.
More about EQL Pharma AB
Average Trading Volume: 18,259
Current Market Cap: SEK2.58B
Learn more about EQL stock on TipRanks’ Stock Analysis page.